Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease

Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Disease

Conditions: ASCVD; Diabetes
Interventions: Behavioral: SMS (Initial Outreach); Behavioral: Secure Portal Message (Initial Outreach); Behavioral: Non-secure Email (Initial Outreach); Behavioral: SMS (Follow-up for Non-responders); Behavioral: Secure Portal Message (Follow-up for Non-responders); Behavioral: Non-secure Email (Follow-up for Non-responders)
Sponsors: Kaiser Permanente
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 14, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments